4.6 Review

Controversies in the pathogenesis of HIV-associated renal diseases

Journal

NATURE REVIEWS NEPHROLOGY
Volume 5, Issue 10, Pages 575-582

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nrneph.2009.139

Keywords

-

Funding

  1. NIAID NIH HHS [AI36219, P30 AI036219] Funding Source: Medline
  2. NIDDK NIH HHS [R03 DK079498, R21 DK077668-02, DK079498, DK061395, DK083375, R21 DK077668, R01 DK061395-08, DK065498, DK077668, R01 DK083375, K08 DK065498, R01 DK061395] Funding Source: Medline
  3. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK079498, R21DK077668, K08DK065498, R01DK061395, R01DK083375] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The two most common HIV-associated renal diseases, HIV-associated nephropathy and HIV immune-complex kidney disease, share the common pathologic finding of hyperplasia within the glomerulus. Podocyte injury is central to the pathogenesis of these diseases; however, the source of the proliferating glomerular epithelial cell remains a topic of debate. Parenchymal injury has been linked to direct infection of renal epithelial cells by HIV-1, although the mechanism of viral entry into this non-lymphoid compartment is unclear. Although transgenic rodent models have provided insight into viral proteins responsible for inducing renal disease, such models have substantial limitations. Rodent HIV-1 models, for instance, cannot replicate all features of immune activation, a process that could have an important role in the pathogenesis of the HIV-associated renal diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available